Table of Content 1 Industry Overview 1.1 PCSK9 Inhibitors Industry 1.1.1 Overview 1.1.2 Products of Major Companies 1.2 Market Segment 1.2.1 Industry Chain 1.2.2 Consumer Distribution 1.3 Price & Cost Overview 2 PCSK9 Inhibitors Market by Type 2.1 By Type 2.1.1 Epatha Evolocumab 2.1.2 Praluent Alirocumab 2.1.3 Bococizumab 2.1.4 Others 2.2 Market Size by Type 2.3 Market Forecast by Type 3 Global Market Demand 3.1 Segment Overview 3.1.1 Clinical Application 3.1.2 Drug Development 3.1.3 Others 3.2 Market Size by Demand 3.3 Market Forecast by Demand 4 Major Region Market 4.1 Global Market Overview 4.1.1 Market Size & Growth 4.1.2 Market Forecast 4.2 Major Region 4.2.1 Market Size & Growth 4.2.2 Market Forecast 5 Major Companies List 5.1 Amgen (Company Profile, Sales Data etc.) 5.2 Eli Lilly (Company Profile, Sales Data etc.) 5.3 Sanofi (Company Profile, Sales Data etc.) 5.4 Pfizer (Company Profile, Sales Data etc.) 5.5 Novartis (Company Profile, Sales Data etc.) 5.6 Roche (Company Profile, Sales Data etc.) 5.7 Merck (Company Profile, Sales Data etc.) 5.8 Alnylam (Company Profile, Sales Data etc.) 5.9 AstraZeneca (Company Profile, Sales Data etc.) 5.10 Affiris (Company Profile, Sales Data etc.) 5.11 BMS (Company Profile, Sales Data etc.) 5.12 Ionis Pharmaceuticals (Company Profile, Sales Data etc.) 5.13 Cyon Therapeutics (Company Profile, Sales Data etc.) 5.14 Daiichi Sankyo (Company Profile, Sales Data etc.) 6 Conclusion

Table Global PCSK9 Inhibitors Market 2015-2018, by Type, in USD Million Table Global PCSK9 Inhibitors Market 2015-2018, by Type, in Volume Table Global PCSK9 Inhibitors Market Forecast 2019-2025, by Type, in USD Million Table Global PCSK9 Inhibitors Market Forecast 2019-2025, by Type, in Volume Table Amgen Overview List Table PCSK9 Inhibitors Business Operation of Amgen (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Eli Lilly Overview List Table PCSK9 Inhibitors Business Operation of Eli Lilly (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Sanofi Overview List Table PCSK9 Inhibitors Business Operation of Sanofi (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Pfizer Overview List Table PCSK9 Inhibitors Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Novartis Overview List Table PCSK9 Inhibitors Business Operation of Novartis (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Roche Overview List Table PCSK9 Inhibitors Business Operation of Roche (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Merck Overview List Table PCSK9 Inhibitors Business Operation of Merck (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Alnylam Overview List Table PCSK9 Inhibitors Business Operation of Alnylam (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table AstraZeneca Overview List Table PCSK9 Inhibitors Business Operation of AstraZeneca (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Affiris Overview List Table PCSK9 Inhibitors Business Operation of Affiris (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table BMS Overview List Table PCSK9 Inhibitors Business Operation of BMS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Ionis Pharmaceuticals Overview List Table PCSK9 Inhibitors Business Operation of Ionis Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Cyon Therapeutics Overview List Table PCSK9 Inhibitors Business Operation of Cyon Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Table Daiichi Sankyo Overview List Table PCSK9 Inhibitors Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin) Figure Global PCSK9 Inhibitors Market Growth 2015-2018, by Type, in USD Million Figure Global PCSK9 Inhibitors Market Growth 2015-2018, by Type, in Volume